Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysis
Sunil Taneja(Indraprastha Apollo Hospitals), Harbir Singh Kohli(Post Graduate Institute of Medical Education and Research), Madhumita Premkumar(Post Graduate Institute of Medical Education and Research), Virendra Singh(Rayat Bahra University), Arka De(Post Graduate Institute of Medical Education and Research), Nipun Verma(Post Graduate Institute of Medical Education and Research), Radha K. Dhiman(Sanjay Gandhi Post Graduate Institute of Medical Sciences), Mini P. Singh(Post Graduate Institute of Medical Education and Research), Ajay Duseja(Post Graduate Institute of Medical Education and Research), Vivek Kumar(Post Graduate Institute of Medical Education and Research), Raja Ramachandran(Post Graduate Institute of Medical Education and Research), Manu Mehta(Post Graduate Institute of Medical Education and Research), Radha Kanta Ratho(Post Graduate Institute of Medical Education and Research)
Cited by 27
Related Papers
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
|Hepatology|2007|599
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
|Mycopathologia|2021|590
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
|Gastroenterology|2018|513
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
|Journal of Hepatology|2012|269
Non‐cirrhotic portal fibrosis (idiopathic portal hypertension): Experience with 151 patients and a review of the literature
|Journal of Gastroenterology and Hepatology|2002|233